Council of EU retains scrutiny procedure for high-risk devices – to an extent
This article was originally published in Clinica
The Council of the EU is recommending that the scope of high-risk medical devices, which would be subject to the European Commission’s proposed “scrutiny procedure” under the new Medical Device Regulation, be substantially whittled down to include Class III implantables only, and not all Class III devices.
You may also be interested in...
A new European Commission guidance document explains the regulatory basics and much- altered emergency market entry criteria for new entrants to devices sector amid the COVID-19 crisis.
The race is now on to get formal adoption of European Commission proposal postponing the MDR by one year and allowing more devices on the market more quickly. But potential hurdles are in the way as experts advise caution.
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.